miRNA-mRNA profile and regulatory network in stearic acid-treated β-cell dysfunction

Area of Science:

• Molecular Biology
• Endocrinology
• Genetics

Background:

• Chronic exposure to saturated fatty acids, like stearic acid, impairs pancreatic beta-cell function and insulin secretion.
• The precise molecular mechanisms driving stearic acid-induced beta-cell dysfunction are not fully understood.
• MicroRNAs (miRNAs) are recognized regulators of diverse biological processes, including cellular function.

Purpose of the Study:

• To investigate differential miRNA and mRNA expression in beta-cells treated with stearic acid versus palmitic acid.
• To construct co-expression networks to elucidate molecular interactions.
• To identify specific miRNAs and mRNAs involved in stearic acid-induced beta-cell lipotoxicity.

Main Methods:

• Beta-TC-6 cells were exposed to stearic acid, palmitic acid, or control medium.
• High-throughput sequencing and bioinformatic analyses were employed to identify differentially expressed miRNAs and mRNAs.
• Co-expression network, Gene Ontology (GO), and pathway analyses were performed; key findings were validated in beta-TC-6 cells and mouse islets.

Main Results:

• Sequencing identified 656 known and 1729 novel miRNAs.
• Two miRNAs (miR-374c-5p and miR-297b-5p) and 63 mRNAs were exclusively differentially expressed in the stearic acid group.
• miR-297b-5p and miR-374c-5p were confirmed to play roles in stearic acid-induced lipotoxicity, affecting candidate mRNA expression.

Conclusions:

• Differential expression of specific miRNAs and mRNAs contributes to stearic acid-induced beta-cell dysfunction.
• This study provides a foundation for further research into the molecular mechanisms of stearic acid-induced beta-cell dysfunction in type 2 diabetes.
• Identifying key miRNAs like miR-297b-5p and miR-374c-5p offers potential therapeutic targets.